I think it’s horses for courses. Some products we will run with fully natural and some synthesis’s CBD etc.
Some treatments may be combos of a natural drug with an already approved traditional drug. I don’t think we will limit ourselves.
I do think it likely we will probably be trying to get a couple of the products the new acquisition has in its quiver ramped up in the market for some early revenue flow.
I expect some sort of video interview in the next week or two perhaps and other media that will elaborate a bit more detail on this deal
Those nervous about the seemingly lowish purchase price of our new company... ask yourself this, would you be happier paying tenfold? No!
Buffet made a career, a fortune from buying undervalued companies with potential and building them.
These guys know exactly what they are buying and what represents good value.
IHL Price at posting:
67.0¢ Sentiment: Buy Disclosure: Held